Re: Cristina Masini, Cinzia Iotti, Ugo De Giorgi, et al. Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. Eur Urol. 2022;81:274-82

Eur Urol. 2022 Apr;81(4):e98-e99. doi: 10.1016/j.eururo.2021.11.034. Epub 2022 Jan 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Renal Cell* / therapy
  • Female
  • Humans
  • Kidney Neoplasms* / therapy
  • Male
  • Nivolumab / therapeutic use
  • Radiosurgery*

Substances

  • Nivolumab